Brent Hatzis-Schoch
2020 - Black Diamond Therapeutics
In 2020, Brent Hatzis-Schoch earned a total compensation of $1.5M as Chief Operating Officer, General Counsel at Black Diamond Therapeutics.
Compensation breakdown
Bonus | $50,000 |
---|---|
Non-Equity Incentive Plan | $184,800 |
Option Awards | $856,811 |
Salary | $418,333 |
Other | $17,100 |
Total | $1,527,044 |
Hatzis-Schoch received $856.8K in option awards, accounting for 56% of the total pay in 2020.
Hatzis-Schoch also received $50K in bonus, $184.8K in non-equity incentive plan, $418.3K in salary and $17.1K in other compensation.
Rankings
In 2020, Brent Hatzis-Schoch's compensation ranked 6,758th out of 13,090 executives tracked by ExecPay. In other words, Hatzis-Schoch earned more than 48.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,758 | 48th |
Manufacturing | 2,817 | 50th |
Chemicals And Allied Products | 1,138 | 50th |
Drugs | 981 | 50th |
Biological Products, Except Diagnostic Substances | 235 | 43rd |
Hatzis-Schoch's colleagues
We found one more compensation record of an executive who worked with Brent Hatzis-Schoch at Black Diamond Therapeutics in 2020.
2020
David Epstein
Black Diamond Therapeutics
Chief Executive Officer
News
Black Diamond Therapeutics CEO David Epstein's 2022 pay falls 68% to $1.6M
April 4, 2023
Black Diamond Therapeutics CEO David Epstein's 2021 pay jumps 32% to $5.1M
April 28, 2022
Radius Health CEO Jesper Hoeiland's 2019 pay falls 28% to $3.9M
April 17, 2020
Radius Health CEO Jesper Høiland's 2018 pay falls 29% to $5.4M
April 18, 2019